Preventive health in your 20s and 30s: what to measure before anything goes wrong

Why the diseases that shorten lives are decades in the making, which numbers show the process while it is still reversible, and what changes if a parent or sibling was diagnosed young.

Key takeaways

Atherosclerosis is measurable in people in their 20s and 30s. Autopsy studies in young adults found early arterial lesions decades before any diagnosis.
The point of measuring young is not a diagnosis. It is a trend line, and a single result at 28 is worth more at 48 than any amount of recalled history.
Family history changes the plan. A parent or sibling with early heart disease is a recognized risk enhancer and a reason to test sooner and more thoroughly.
Lp(a) is largely genetic and stable, so testing it once tells you something permanent that a standard cholesterol panel misses.
Prediabetes is common and usually unrecognized, and the Diabetes Prevention Program showed lifestyle change cut progression to type 2 diabetes by 58 percent.
Most of what you would do with these numbers at this age is not a prescription. It is training, sleep, body composition and food, aimed with real data.

The conditions that end most lives do not begin in the decade they are diagnosed. Atherosclerosis and insulin resistance are measurable years before a diagnosis exists.

That is the entire argument for measuring early. You cannot act on a trend you never started recording.

The diseases are decades old before they are diagnosed

The Pathobiological Determinants of Atherosclerosis in Youth studies examined arteries from young people who died of unrelated causes and found fatty streaks and raised lesions in adolescents and young adults, with extent tracking the risk factors those individuals carried. The Bogalusa Heart Study found the same association between risk factor levels measured in life and arterial disease found later.

Insulin resistance follows the same pattern. Fasting insulin rises years before glucose does, and glucose rises years before a diabetes diagnosis. By the time a standard panel flags a fasting glucose, the process has usually been running for a long time.

This is the whole argument for early measurement. Waiting until a number crosses a diagnostic threshold means waiting until the cheapest and most reversible window has closed.

What a first baseline should include

A lipid panel with ApoB. ApoB counts the particles that carry cholesterol into the artery wall, which is closer to the mechanism than LDL cholesterol alone.
Lp(a), once. It is set largely by genetics and stays roughly stable for life, and it is one of the more common inherited drivers of early heart disease. One test answers it permanently.
Fasting insulin and glucose, for HOMA-IR, plus HbA1c. The pair catches insulin resistance well before glucose moves.
hs-CRP, drawn when you are well rather than during an illness.
A comprehensive metabolic panel and a full blood count, including ferritin.
25-hydroxyvitamin D.
TSH with free T4.
Sex hormones where symptoms or history warrant it. Total testosterone with SHBG in men, drawn in the morning. Cycle history and, where relevant, estradiol and FSH in women.
Blood pressure, measured properly and more than once.
Body composition, ideally DEXA, and a real cardiorespiratory fitness measure. Fitness is one of the strongest available predictors of long term mortality, and the scale tells you nothing about the muscle to fat ratio underneath it.

If you have a family history

Premature cardiovascular disease in a first degree relative, meaning a father or brother before 55 or a mother or sister before 65, is treated in current cardiology guidelines as a risk enhancing factor, and it is a reason to be more thorough rather than more relaxed.

Familial hypercholesterolemia is worth knowing about specifically. It affects roughly 1 in 250 people, it produces high LDL from childhood, and most people who have it have never been told. A very high LDL or ApoB in a young adult, especially with a family history of early heart attacks, is the pattern that should trigger that question.

Family history of type 2 diabetes, early stroke, certain cancers, autoimmune thyroid disease or osteoporosis all shift what gets measured and how often. Bring the specifics, including ages at diagnosis. Ages matter more than the diagnosis list.

Early heart disease in a first degree relative: test ApoB and Lp(a) early, take blood pressure seriously, and do not dismiss a borderline result because of your age.
Type 2 diabetes in a parent or sibling: HOMA-IR and HbA1c, tracked, plus a serious look at training and visceral fat.
Familial hypercholesterolemia pattern: this is a clinical evaluation, not a supplement question.
Osteoporosis or early fracture in family: get body composition and discuss timing of bone density with a provider, and load your skeleton now.

What you actually do with the results

At this age, most of the useful actions are not prescriptions. Resistance training two to three times a week, cardiovascular work that pushes your fitness rather than just filling time, protein high enough to hold muscle, fiber, sleep treated as a fixed appointment, and alcohol counted honestly. Those are the interventions with the largest effect on every number listed above.

The Diabetes Prevention Program is the clearest demonstration. In people with prediabetes, a structured lifestyle program reduced progression to type 2 diabetes by 58 percent, outperforming metformin at 31 percent. That is what acting early looks like when it is measured properly.

Where a marker is already clearly abnormal, or where family history suggests an inherited condition, that becomes a clinical conversation. Optimization and prevention are the same project approached from different distances.

How often to repeat

Lp(a): once, unless something clinically changes.
Lipids with ApoB, HbA1c, fasting insulin and glucose, hs-CRP: annually if normal, sooner if you are changing something and want to see whether it worked.
Vitamin D and ferritin: annually, or after correcting a low result to confirm it moved.
Body composition and fitness: every six to twelve months, because these change fast enough to be motivating.
Blood pressure: at home, periodically, not only at appointments.

How this works here

Baseline is built around this sequence. Intake and history, then recommended lab work if you choose it, then an independent licensed physician reviewing what is available before anything is recommended. For a lot of people in their 20s and 30s the right answer after that review is training, sleep and nutrition with a repeat panel later, and we would rather tell you that than sell you a protocol you do not need.

The Biomarker hub explains each of the individual markers above in more depth, and the calculators in our tools section let you work out HOMA-IR, ApoB context, ratios, fitness and body composition from results you already have.

What this means for you

Get a real baseline while everything still looks normal, know your family's ages at diagnosis, and test Lp(a) once. The point is not to find something wrong today. It is to own a trend line, because the conditions that shorten lives are already in motion long before they are diagnosed.

Therapies discussed here

NAD+

References

McGill HC, et al., Pathobiological Determinants of Atherosclerosis in Youth (PDAY), effects of risk factors on early atherosclerotic lesions, American Journal of Cardiology, 1998
Berenson GS, et al., association between multiple cardiovascular risk factors and atherosclerosis in children and young adults (Bogalusa Heart Study), New England Journal of Medicine, 1998
Grundy SM, et al., 2018 AHA/ACC multisociety guideline on the management of blood cholesterol, Circulation, 2019
Kronenberg F, et al., European Atherosclerosis Society consensus statement on lipoprotein(a), European Heart Journal, 2022
Nordestgaard BG, et al., familial hypercholesterolaemia is underdiagnosed and undertreated in the general population, European Atherosclerosis Society consensus statement, European Heart Journal, 2013
Knowler WC, et al., reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (Diabetes Prevention Program), New England Journal of Medicine, 2002
Matthews DR, et al., homeostasis model assessment, insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 1985
Mandsager K, et al., association of cardiorespiratory fitness with long term mortality among adults undergoing exercise treadmill testing, JAMA Network Open, 2018
American Diabetes Association, standards of care in diabetes, classification and diagnosis of diabetes